Differential expression of neural-cadherin in pulmonary epithelial tumours

Histopathology

Volumn 52, Issue 3, 2008, Pages 348-354

  Zynger, D L ^a,b   Dimov, N D ^a   Ho, L C ^a   Laskin, W B ^a   Yeldandi, A V ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN MEMORIAL HOSPITAL   (United States)

Author keywords

Atypical carcinoid; N cadherin; Neuroendocrine; Pulmonary; Typical carcinoid

Indexed keywords

NERVE CELL ADHESION MOLECULE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL NEUROENDOCRINE CARCINOMA; LUNG ADENOCARCINOMA; LUNG ALVEOLUS EPITHELIUM; LUNG SMALL CELL CANCER; LUNG TUMOR; LYMPH NODE; MALE; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; CADHERINS; CARCINOID TUMOR; CARCINOMA, NEUROENDOCRINE; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; HUMANS; HYPERPLASIA; IMMUNOENZYME TECHNIQUES; LUNG NEOPLASMS; NEUROSECRETORY SYSTEMS; TUMOR MARKERS, BIOLOGICAL;

EID: 38849165170     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2007.02952.x     Document Type: Article

References (34)

1. Takeichi M. The cadherins: cell-cell adhesion molecules controlling animal morphogenesis. Development 1988 102 639 655.
2. Potter E, Bergwitz C, Brabant G. The cadherin-catenin system: implications for growth and differentiation of endocrine tissues. Endocr. Rev. 1999 20 207 239.
3. Guarino M. Epithelial-to-mesenchymal change of differentiation. From embryogenetic mechanism to pathological patterns. Histol. Histopathol. 1995 10 171 184.
4. Frisch SM. The epithelial cell default-phenotype hypothesis and its implications for cancer. Bioessays 1997 19 705 709.
5. Monier-Gavelle F, Duband JL. Control of N-cadherin-mediated intercellular adhesion in migrating neural crest cells in vitro. J. Cell Sci. 1995 108 (Pt 12 3839 3853.
6. Birchmeier C, Birchmeier W, Brand-Saberi B. Epithelial-mesenchymal transitions in cancer progression. Acta Anat (Basel) 1996 156 217 226.
7. Nieman MT, Prudoff RS, Johnson KR, Wheelock MJ. N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J. Cell Biol. 1999 147 631 644.
8. Hazan RB, Phillips GR, Qiao RF, Norton L, Aaronson SA. Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J. Cell Biol. 2000 148 779 790.
9. Li G, Satyamoorthy K, Herlyn M. N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells. Cancer Res. 2001 61 3819 3825.
10. Hsu MY, Wheelock MJ, Johnson KR, Herlyn M. Shifts in cadherin profiles between human normal melanocytes and melanomas. J. Investig. Dermatol. Symp. Proc. 1996 1 188 194.
11. Tomita K, van Bokhoven A, van Leenders GJ et al. Cadherin switching in human prostate cancer progression. Cancer Res. 2000 60 3650 3654.
12. Hazan RB, Qiao R, Keren R, Badano I, Suyama K. Cadherin switch in tumor progression. Ann. NY Acad. Sci. 2004 1014 155 163.
13. Travis WD, Rush W, Flieder DB et al. Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid. Am. J. Surg. Pathol. 1998 22 934 944.
14. Sandler AB. Chemotherapy for small cell lung cancer. Semin. Oncol. 2003 30 9 25.
15. Spira A, Ettinger DS. Multidisciplinary management of lung cancer. N. Engl. J. Med. 2004 350 379 392.
16. Pelosi G, Rodriguez J, Viale G, Rosai J. Typical and atypical pulmonary carcinoid tumor overdiagnosed as small-cell carcinoma on biopsy specimens: a major pitfall in the management of lung cancer patients. Am. J. Surg. Pathol. 2005 29 179 187.
17. Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC. Pathology and genetics of tumours of the lung, pleura, thymus and heart. New York : Oxford University Press Inc., 2004.
18. Hatta K, Takagi S, Fujisawa H, Takeichi M. Spatial and temporal expression pattern of N-cadherin cell adhesion molecules correlated with morphogenetic processes of chicken embryos. Dev. Biol. 1987 120 215 227.
19. Derycke LD, Bracke ME. N-cadherin in the spotlight of cell-cell adhesion, differentiation, embryogenesis, invasion and signalling. Int. J. Dev. Biol. 2004 48 463 476.
20. Harpole DH Jr., Feldman JM, Buchanan S, Young WG, Wolfe WG. Bronchial carcinoid tumors: a retrospective analysis of 126 patients. Ann. Thorac. Surg. 1992 54 50 54.
21. Khorram-Manesh A, Ahlman H, Jansson S, Nilsson O. N-cadherin expression in adrenal tumors: upregulation in malignant pheochromocytoma and downregulation in adrenocortical carcinoma. Endocr. Pathol. 2002 13 99 110.
22. Zarka TA, Han AC, Edelson MI, Rosenblum NG. Expression of cadherins, p53, and BCL2 in small cell carcinomas of the cervix: potential tumor suppressor role for N-cadherin. Int. J. Gynecol. Cancer 2003 13 240 243.
23. Han AC, Soler AP, Tang CK, Knudsen KA, Salazar H. Nuclear localization of E-cadherin expression in Merkel cell carcinoma. Arch. Pathol. Lab. Med. 2000 124 1147 1151.
24. Utsuki S, Sato Y, Oka H, Tsuchiya B, Suzuki S, Fujii K. Relationship between the expression of E-, N-cadherins and beta-catenin and tumor grade in astrocytomas. J. Neurooncol. 2002 57 187 192.
25. Liu Y, Sturgis CD, Grzybicki DM. Microtubule-associated protein-2: a new sensitive and specific marker for pulmonary carcinoid tumor and small cell carcinoma. Mod. Pathol. 2001 14 880 885.
26. Matsuki Y, Tanimoto A, Hamada T, Sasaguri Y. Histidine decarboxylase expression as a new sensitive and specific marker for small cell lung carcinoma. Mod. Pathol. 2003 16 72 78.
27. Lantuejoul S, Moro D, Michalides RJ, Brambilla C, Brambilla E. Neural cell adhesion molecules (NCAM) and NCAM-PSA expression in neuroendocrine lung tumors. Am. J. Surg. Pathol. 1998 22 1267 1276.
28. Lyda MH, Weiss LM. Immunoreactivity for epithelial and neuroendocrine antibodies are useful in the differential diagnosis of lung carcinomas. Hum. Pathol. 2000 31 980 987.
29. Jiang SX, Kameya T, Asamura H et al. hASH1 expression is closely correlated with endocrine phenotype and differentiation extent in pulmonary neuroendocrine tumors. Mod. Pathol. 2004 17 222 229.
30. Peralta Soler A, Knudsen KA, Jaurand MC et al. The differential expression of N-cadherin and E-cadherin distinguishes pleural mesotheliomas from lung adenocarcinomas. Hum. Pathol. 1995 26 1363 1369.
31. Abutaily AS, Addis BJ, Roche WR. Immunohistochemistry in the distinction between malignant mesothelioma and pulmonary adenocarcinoma: a critical evaluation of new antibodies. J. Clin. Pathol. 2002 55 662 668.
32. Nakashima T, Huang C, Liu D et al. Neural-cadherin expression associated with angiogenesis in non-small-cell lung cancer patients. Br. J. Cancer 2003 88 1727 1733.
33. Ordonez NG. Value of E-cadherin and N-cadherin immunostaining in the diagnosis of mesothelioma. Hum. Pathol. 2003 34 749 755.
34. Ordonez NG. The immunohistochemical diagnosis of mesothelioma: a comparative study of epithelioid mesothelioma and lung adenocarcinoma. Am. J. Surg. Pathol. 2003 27 1031 1051.